The Lancet Haematology (LH)
Journal Descriptions
The Lancet Haematology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, review, and opinion covering international issues, providing a clear, independent perspective about the clinical advances and practice-changing research shaping clinical haematology. The Lancet Haematology is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.
The Lancet Haematology (LH) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Hematology, Medicine , Online or Print , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2451-9960, E-ISSN: 2352-3026, Established: 2014, Impact Factor: 24.7
- Does Not Provide Crossref DOI
-
Indexed in: Scopus, WoS
-
Not indexed in DOAJ, PubMed, UGC CARE
